Skip to main content
. 2022 Jun 15;18(1):35–42. doi: 10.17925/EE.2022.18.1.35

Figure 2: An upstream weight-centric approach versus more downstream, glucose-centric and cardiometabolic approaches. Incretin-based therapies are already active at the most upstream step.

Figure 2:

T2D = type 2 diabetes mellitus.